Prescribing information for:

FERINJECT^®(ferric carboxymaltose) FILSPARI^®(sparsentan): 200 mg FILSPARI^®(sparsentan): 400 mg AVACOPAN VIFOR VELTASSA^®(patiromer): 8.4 g dose VELTASSA^®(patiromer): 16.8g dose KAPRUVIA^®(difelikefalin)

Engage Academy

Your bank of resources to support your treatment goals for patients

Engage Academy

Your bank of resources to support your treatment goals for patients

Home

/

Engage Academy

All Academy Webinars

Adverse events should be reported. Reporting forms and information for the United Kingdom can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Fresenius Medical Care Renal Pharma, care of Vifor Pharma Ltd.
Tel: +44 1276 853633. E-mail: MedicalInfo_UK@viforpharma.com.

Stay informed

Register with CSL for the latest releases. This will include promotional content

Products

Explore CSL medicines & products